Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for resistant and relapsing multiple myeloma.

R Alexanian, B Barlogie, G Ventura

    European Journal of Haematology. Supplementum
    |January 1, 1989
    PubMed
    Summary

    For multiple myeloma patients resistant to standard chemotherapy, intensive treatment regimens like high-dose melphalan and chemoradiotherapy show promise. These advanced therapies can lead to longer remission durations for refractory disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MALDI mass spectrometry imaging in plant and food lipidomics: advances, challenges, and future perspectives.

    Molecular omics·2025
    Same author

    Effect of age, stress and protein supply on plasma amino acids during continuous enteral nutrition; a pragmatic study in rats.

    Clinical nutrition (Edinburgh, Scotland)·2021
    Same author

    Microencapsulated and uncoated butyric acid as alternative additives to the regeneration of intestinal mucosa in broilers challenged with <i>Eimeria</i> spp.

    British poultry science·2021
    Same author

    <i>Agaricus subrufescens</i> and <i>Pleurotus ostreatus</i> mushrooms as alternative additives to antibiotics in diets for broilers challenged with <i>Eimeria</i> spp.

    British poultry science·2020
    Same author

    Correlation between tectonic CO<sub>2</sub> Earth degassing and seismicity is revealed by a 10-year record in the Apennines, Italy.

    Science advances·2020
    Same author

    Effect of aging on the availability of amino acids from an immune-enhancing diet (IED) after a surgical stress in rats.

    Clinical nutrition (Edinburgh, Scotland)·2019

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Research

    Background:

    • Multiple myeloma is a hematologic malignancy often developing resistance to standard chemotherapy.
    • Treatment options for relapsed or refractory multiple myeloma remain a significant clinical challenge.

    Purpose of the Study:

    • To summarize experience in treating multiple myeloma patients resistant to standard chemotherapy.
    • To evaluate the efficacy of various salvage regimens and intensive therapies in refractory multiple myeloma.

    Main Methods:

    • Retrospective review of patients with relapsed or refractory multiple myeloma.
    • Analysis of treatment responses and outcomes for VAD (vincristine, doxorubicin, dexamethasone) regimen.
    • Evaluation of high-dose therapies including intravenous melphalan, CBV (cyclophosphamide-BCNU-VP-16), EDAP (VP-16-platinum), and high-dose melphalan with total body irradiation, often supported by autologous stem cell transplantation.

    Related Experiment Videos

    Main Results:

    • The VAD regimen achieved remissions in approximately 50% of relapsing patients and 25% of previously unresponsive patients.
    • High-dose therapies (melphalan, CBV, EDAP) in VAD-resistant patients yielded responses in about 40%, with a median control duration of 6 months, typically requiring stem cell support.
    • An intensive program of high-dose melphalan and total body irradiation with autologous bone marrow support resulted in responses for all surviving patients, with a median control duration of 1 year.

    Conclusions:

    • A dose-response effect of chemoradiotherapy was observed in VAD-resistant multiple myeloma.
    • Intensive treatment regimens, including high-dose melphalan and total body irradiation, demonstrate potential for prolonging disease-free survival in refractory multiple myeloma.